PPARG and scleroderma: Other nonthiazolidinic PPARγ ligands, AjA and CDDO, also reduced collagen neosynthesis by scleroderma fibroblasts in vitro, an action that was reversed completely by cotreatment with a selective PPARγ antagonist [27, 69].